CEO Doubles Down. Third Insider This Month.
CEO Wong drops $160K at $1.41, marking the third insider buy in 30 days on this biotech. The technicals are stacked with 72% buy signals across all timeframes and RSI sitting in the sweet spot at 63. Fair warning though — insiders on this name have struggled historically, with previous buys showing negative alpha over 90 days. The cluster pattern and strong momentum suggest this time could be different, but biotech is unforgiving territory.
The Filing
| Ticker | HCWB |
| Company | HCW Biologics Inc. |
| Insider | Hing Wong, Chief Executive Officer |
| Buy amount | $160,000 |
| Filing date | May 27, 2026 |
| Conviction | Interesting · 57/100 |
| Setup type | Trend Confirmation |
Ultimate members received this analysis in real time.